04Jun/13

Meet the crusaders for organ donation – Irish Independent


Irish Independent

Meet the crusaders for organ donation
Irish Independent
“If you inform people young, it will just become a done thing,” Clare explains, citing a US study that showed that 90pc of people supported organ donation, but only 30pc held organ donor cards. Her classmate Clodagh Martin found that lack of awareness
Organ donation: Public to be consulted on proposed law changeBBC News
A legacy of lifeSuffolk News-Herald

all 4 news articles »

04Jun/13

Novartis phase III trial shows Afinitor delays tumour growth in HER2 positive … – pharmabiz.com

Novartis phase III trial shows Afinitor delays tumour growth in HER2 positive
pharmabiz.com
Novartis has presented results from a pivotal phase III trial of a treatment regimen including Afinitor (everolimus) tablets in women with human epidermal growth factor receptor-2 positive (HER2 positive) advanced breast cancer who received prior
Novartis pivotal Phase III trial shows Afinitor® significantly delays tumor PR Newswire (press release)
Novartis reports positive breast cancer data for AfinitorZenopa
NOVARTIS AG : pivotal Phase III trial shows Afinitor® significantly delays 4-traders (press release)

all 5 news articles »

04Jun/13

Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell … – MarketWatch

Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell
MarketWatch
Study Evaluating REVLIMID(R) Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at ASCO. MEL200 demonstrated a longer median PFS and OS compared
MEL200 demonstrated a longer median PFS and OS compared to MPR in the Investor’s Business Daily
ASCO 2012 Multiple Myeloma Update – Day Three: Poster PresentationsThe Myeloma Beacon

all 9 news articles »